Matarin Capital Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$2.52M Sell
203,655
-97,977
-32% -$1.06M 0.62% 74
2020
Q3
$3.15M Sell
301,632
-38,396
-11% -$488K 0.66% 66
2020
Q2
$4.75M Sell
340,028
-225,627
-40% -$3.07M 0.95% 23
2020
Q1
$6.65M Sell
565,655
-29,333
-5% -$388K 1.03% 14
2019
Q4
$8.43M Sell
594,988
-269,201
-31% -$3.3M 0.81% 33
2019
Q3
$9.11M Sell
864,189
-50,277
-5% -$601K 0.69% 61
2019
Q2
$13.3M Buy
914,466
+12,431
+1% +$176K 0.95% 23
2019
Q1
$12.7M Buy
902,035
+38,866
+5% +$629K 0.92% 25
2018
Q4
$15.1M Buy
863,169
+725,780
+528% +$11.8M 1.22% 7
2018
Q3
$2.09M Buy
137,389
+29,629
+27% +$427K 0.14% 175
2018
Q2
$1.49M Buy
+107,760
New +$1.61M 0.11% 185

Other funds holding INVA

Matarin Capital Management's INVA Position: Q4 2020 in Review

Matarin Capital Management reduced its Innoviva (INVA) stake by 32% in Q4 2020, selling an estimated $1.06M and leaving 203,655 shares worth $2.52M. The position accounts for 0.62% of the portfolio, ranked #74.

Matarin Capital Management first reported a position in INVA in Q2 2018 and has held it in 11 quarters since. The position peaked at $15.1M in Q4 2018. 194 funds tracked by Wall St. Rank hold INVA as of Q4 2020.

  • Matarin Capital Management held 203,655 shares of Innoviva worth $2.52M as of Q4 2020.
  • Matarin Capital Management sold 97,977 Innoviva shares in Q4 2020, an estimated $1.06M.
  • Innoviva made up 0.62% of Matarin Capital Management's portfolio in Q4 2020, its #74 holding.
  • Matarin Capital Management first reported a position in Innoviva in Q2 2018 and has held it in 11 quarters since.
  • Matarin Capital Management's Innoviva position peaked at $15.1M in Q4 2018.
  • 194 funds tracked by Wall St. Rank held Innoviva as of Q4 2020.

Based on Matarin Capital Management's 13F filing for Q4 2020, filed 3 Feb 2021.